Skip to main content
ByMay 12, 2026~9 min read

Camtek in the first quarter: strong orders move the proof to the second half

Camtek opened 2026 with nearly flat revenue and lower operating profit, while management pointed to a second half more than 25% above the first half. This quarter does not prove the breakout yet; it raises the bar for converting strong orders into revenue, margin and cash.

CompanyCamtek

Camtek did not report a weak quarter, but it also did not report the kind of quarter that proves the step-up investors are looking for in 2026. Revenue increased only 2.5% to $121.7 million, operating profit fell 17%, and operating cash flow was only $3.1 million against net income of $31.6 million. On the other side, management described an exceptional start to the year in incoming orders, and on March 30, 2026 the company had already said Q1 orders from leading OSATs exceeded $90 million, mostly for CoWoS-like packaging applications supporting AI and expected to be delivered this year. That makes Q1 less a proof of breakout and more a transition quarter: the orders may already be there, but revenue, margins and cash still have to catch up. The next checkpoint is not just Q2 growth, but whether the implied second-half ramp arrives without further operating-margin erosion or additional working-capital pressure. This naturally continues the previous annual analysis, which framed 2026 as Hawk's proof year: Q1 strengthens the demand signal, but it does not yet close the test of broader revenue conversion.

Company Overview

Camtek develops and manufactures inspection and metrology equipment for the semiconductor industry. Its systems inspect wafers and measure features across several production stages, from front-end and mid-end processes through the beginning of post-dicing assembly. In economic terms, this is a semiconductor-equipment company driven by two engines: capital spending around advanced packaging, HBM, chiplets and AI applications, and the ability to charge high prices for accuracy, throughput and software capabilities around critical inspection steps.

This is not a simple growth story. It depends on investment cycles at large customers, qualification timelines, timely system delivery, and the conversion of backlog and pipeline into recognized revenue. Q1 2026 therefore has to be read through three layers: whether demand is truly strong, whether the added cost base is running ahead of future growth or weighing on profitability, and whether reported profit turns into cash.

Camtek says the year began with an unprecedented level of incoming orders and bases its outlook on backlog and pipeline. This time there is also a number behind that statement: a $31 million order from a leading OSAT, an outsourced semiconductor assembly and test provider, lifted total Q1 orders from leading OSAT customers to more than $90 million. Still, the company does not break down the full backlog by product, customer or geography. The reader receives a strong direction, not a full dissection of demand quality. In the next few quarters, the question is whether Hawk orders, OSAT orders and the new AI capabilities convert into broader revenue, or whether the story remains too dependent on a limited number of customers and delivery timing.

The First Quarter Does Not Yet Prove the Breakout

The important number in the first quarter is not revenue growth, but the gap between nearly flat revenue and a cost base that has already stepped up. Revenue was $121.7 million, up 2.5% from $118.6 million in the same quarter last year. GAAP gross profit barely moved, $60.9 million versus $60.6 million, but GAAP gross margin declined to 50.1% from 51.0%.

The pressure is sharper at the operating line. GAAP operating profit fell to $27.3 million from $32.7 million, and the operating margin declined to 22.4% from 27.6%. The non-GAAP picture is similar: operating profit of $31.1 million, down 17%, and a margin of 25.5% versus 31.5% a year earlier.

MetricQ1 2026Q1 2025What it means
Revenue$121.7 million$118.6 million2.5% growth, not yet a run-rate jump
GAAP gross margin50.1%51.0%The 2025 margin improvement did not strengthen further in Q1
GAAP operating profit$27.3 million$32.7 millionDown 17%, mainly because expenses rose faster
Research and development expenses$14.3 million$10.4 millionUp 38%, investment ahead of revenue proof
Selling, general and administrative expenses$19.3 million$17.5 millionUp 10.5%, the operating base is expanding

The rise in R&D matters more than the line item itself. Management points to investment in AI algorithms, software, detection, metrology and classification capabilities, including progress around Visual Layer, whose acquisition has recently closed. This may be exactly the type of investment needed to widen the product advantage. But until revenue accelerates more clearly, that same investment shows up as lower profitability.

This is not an immediate balance-sheet problem. It is a timing test. If the second half brings the revenue step-up management is pointing to, Q1 expenses will look like proper preparation. If the acceleration slips, the market will read this quarter as a sign that the cost base moved ahead of revenue.

The Second-Half Outlook Raises the Execution Bar

The strongest part of the release is not Q1 itself, but the outlook. Management guided Q2 revenue to $129 million to $131 million. At the midpoint, that is about $130 million, up roughly 6.9% from Q1. That is an improvement, but it does not by itself explain the larger 2026 story.

The March order update makes management's tone more concrete. Q1 orders from leading OSAT customers exceeded $90 million, mostly for CoWoS-like packaging applications supporting AI. The systems are expected to be delivered during 2026, so this supports the second-half outlook. It also sharpens the revenue-recognition test: if the orders are for delivery this year, the next reports should start showing that in the revenue run rate.

The more important number sits in the second half. If Q2 lands near the midpoint, first-half revenue would be about $251.7 million. Management's expectation that second-half revenue will be more than 25% higher than first-half revenue implies more than roughly $314.6 million of revenue across the final two quarters. In other words, the average revenue run rate in Q3 and Q4 has to be materially higher than in Q1 and Q2.

The 2026 outlook shifts the weight to the second half

The chart is not a full official annual forecast. It shows the numerical implication of Q2 guidance and management's second-half comment. It highlights the size of the execution test: for the message to hold, Camtek must move from an almost flat first quarter to a much higher revenue run rate in the second half.

This is where the Hawk story continues. In the analysis of Hawk commercialization, the key checkpoint was whether previously disclosed orders represented depth at one customer or broader commercial adoption. Q1 does not fully answer that. It gives a positive signal through management's tone and second-half outlook, but it does not break down orders by customer or system. 2026 still looks like a proof year, not a year in which the proof has already been completed.

Cash Flow Reminds Us That Orders Are Not Cash

The yellow flag in Q1 is cash flow. Camtek reported net income of $31.6 million, but operating cash flow was only $3.1 million. Because the quarterly release does not provide a detailed cash-flow bridge, it is not possible to identify precisely which working-capital line consumed most of the cash. Still, the balance sheet points in a clear direction: trade receivables rose to $131.7 million from $90.8 million at the end of 2025, a 45% increase.

That matters in an equipment company. Revenue from a system can look strong in the income statement, while cash follows payment terms, delivery and installation completion. In a quarter where management is discussing exceptional orders and preparing investors for a strong second half, a sharp receivables increase is not automatically negative. It does move the test from orders and margins to collection and profit-to-cash conversion.

Inventory is not telling the same pressure story right now. Current inventory declined to $100.0 million from $112.2 million at the end of 2025, and total inventory including the long-term layer declined to about $116.7 million from $127.8 million. That reinforces the conclusion from the previous inventory analysis: the issue is not a gross build-up of finished systems, but the balance between operating readiness, delivery pace and collection.

The overall cash position remains comfortable. Cash, deposits and marketable securities totaled $849.7 million at the end of March, almost unchanged from $851.1 million at the end of 2025. Against that, convertible notes had a balance-sheet value of $487.8 million, so net liquidity after the convertible debt increased to about $361.9 million. That leaves the company with financial flexibility, but it does not cancel the operating cash test. In the next few quarters, the question is whether the higher revenue run rate also converts into operating cash flow, not just a larger receivables balance.

Conclusion

Camtek's first quarter creates a mixed but not neutral conclusion. The demand described by management sounds strong, Q2 guidance supports gradual improvement, and the expectation for a second half more than 25% above the first half sets a clear growth path. But the numbers already reported still do not prove that path: revenue is nearly flat, operating margin has compressed, and operating cash flow is weak relative to net income.

The current read is that 2026 remains a proof year, now with a higher bar. For the read to improve, the company needs to show three things together over the next three quarters: revenue acceleration consistent with the second-half outlook, operating-margin recovery after the early investment in AI and software, and collection that brings operating cash flow back closer to reported profit. The counter-thesis is that exceptional orders already provide enough visibility, and Q1 simply catches the company before the delivery ramp. That is possible, but it is not yet proven. The market is likely to judge the next reports less by the headline of strong orders and more by whether those orders reach revenue, operating profit and cash.

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction